# Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

> **NCT03352206** · — · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 20092 (actual)

## Conditions studied

- Lymphatic Filariases

## Interventions

- **DRUG:** 2 drug dose - DA
- **DRUG:** 3 drug dose - IDA

## Key facts

- **NCT ID:** NCT03352206
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-18
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 20092 (ACTUAL)
- **Last updated:** 2020-12-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03352206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03352206, "Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03352206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*